# Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases

> **NCT05324917** · — · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 20 (estimated)

## Conditions studied

- Rituximab
- Children
- Blood Disease

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Rituximab (once a week)

## Key facts

- **NCT ID:** NCT05324917
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-10
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05324917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05324917, "Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT05324917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*